Showing results (71-80 of 179) with videos related to
Sort By:
Pageof 18
Bioorganic & Medicinal Chemistry|April 11, 2009
Design, synthesis, and quantitative structure-activity relationship of cytotoxic gamma-carboline derivativesJing Chen, Xiaowu Dong, Tao Liu, et al.European Journal of Medicinal Chemistry|December 10, 2013
Design, synthesis, and biological evaluation of novel piperidine-4-carboxamide derivatives as potent CCR5 inhibitorsSuwen Hu, Quan Gu, Zhilong Wang, et al.Cancer Letters|February 20, 2010
Abrogation of Akt signaling by Isobavachalcone contributes to its anti-proliferative effects towards human cancer cellsHui Jing, Xinglu Zhou, Xiaowu Dong, et al.Journal of Medicinal Chemistry|February 9, 2022
Identification of 2-Aminopyrimidine Derivatives as FLT3 Kinase Inhibitors with High Selectivity over c-KITLexian Tong, Peipei Wang, Xuemei Li, et al.Briefings in Bioinformatics|April 6, 2023
ClusterX: a novel representation learning-based deep clustering framework for accurate visual inspection in virtual screeningSikang Chen, Jian Gao, Jiexuan Chen, et al.BMC Cancer|February 24, 2023
Peripheral immune cell profiling of double-hit lymphoma by mass cytometryTao Lei, Gongqiang Wu, Yongjin Xu, et al.Journal of Medicinal Chemistry|October 3, 2025
Development of Dual FLT3 and CHK1 PROTACs for the Treatment of AMLXuanmin Lian, Yue Gao, Wenjing Du, et al.Nucleic Acids Research|October 3, 2020
PROTAC-DB: an online database of PROTACsGaoqi Weng, Chao Shen, Dongsheng Cao, et al.The Journal of Physical Chemistry. B|February 9, 2018
Benchmark Study Based on 2P2IDB to Gain Insights into the Discovery of Small-Molecule PPI InhibitorsZhe Wang, Yu Kang, Dan Li, et al.Bioorganic Chemistry|June 20, 2024
Discovery and characterization of novel FGFR1 inhibitors in triple-negative breast cancer via hybrid virtual screening and molecular dynamics simulationsYuchen Wang, Zheyuan Shen, Roufen Chen, et al.Pageof 18